HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jasti S Rao Selected Research

Cathepsin B

4/2021Retraction Note to: uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma.
5/2014uPAR and cathepsin B-mediated compartmentalization of JNK regulates the migration of glioma-initiating cells.
10/2013Knockdown of cathepsin B and uPAR inhibits CD151 and α3β1 integrin-mediated cell adhesion and invasion in glioma.
3/2013Cathepsin B as a cancer target.
3/2013Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression.
8/2012uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton of glioma-initiating cells.
6/2012uPAR and cathepsin B inhibition enhanced radiation-induced apoptosis in gliomainitiating cells.
3/2012uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma.
2/2012Metabolic remodeling precedes mitochondrial outer membrane permeabilization in human glioma xenograft cells.
1/2012Integrin α9β1-mediated cell migration in glioblastoma via SSAT and Kir4.2 potassium channel pathway.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jasti S Rao Research Topics

Disease

98Neoplasms (Cancer)
11/2020 - 08/2002
64Glioma (Gliomas)
04/2021 - 01/2002
26Glioblastoma (Glioblastoma Multiforme)
01/2021 - 11/2002
16Neoplasm Metastasis (Metastasis)
10/2013 - 10/2005
14Meningioma (Meningiomas)
01/2021 - 02/2003
9Medulloblastoma
05/2014 - 05/2007
8Infections
06/2008 - 11/2002
7Prostatic Neoplasms (Prostate Cancer)
11/2020 - 04/2005
7Brain Neoplasms (Brain Tumor)
10/2013 - 12/2002
6Breast Neoplasms (Breast Cancer)
09/2011 - 04/2006
5Spinal Cord Injuries (Spinal Cord Injury)
09/2012 - 01/2008
5Lung Neoplasms (Lung Cancer)
09/2010 - 09/2005
4Neuroblastoma
01/2013 - 01/2012
4Hypoxia (Hypoxemia)
01/2012 - 09/2010
2Pancreatic Neoplasms (Pancreatic Cancer)
09/2013 - 04/2011
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2013 - 04/2011
2Leukemia
01/2013 - 04/2005
2Inflammation (Inflammations)
06/2012 - 10/2009
2Adenocarcinoma
02/2012 - 04/2011
2Heart Failure
05/2010 - 08/2009
2Pathologic Processes
10/2009 - 11/2002
1Stroke (Strokes)
02/2014
1Brain Ischemia (Cerebral Ischemia)
02/2014

Drug/Important Bio-Agent (IBA)

44Small Interfering RNA (siRNA)IBA
05/2014 - 05/2004
36Proteins (Proteins, Gene)FDA Link
05/2014 - 12/2002
32Urokinase Plasminogen Activator ReceptorsIBA
11/2020 - 01/2002
25Cathepsin BIBA
04/2021 - 12/2002
20Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2020 - 11/2002
20Peptide Hydrolases (Proteases)FDA Link
09/2012 - 02/2003
19Matrix Metalloproteinases (MMPs)IBA
01/2021 - 02/2003
15Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2020 - 11/2002
15Plasminogen Activators (Plasminogen Activator)IBA
11/2020 - 02/2003
15matrigelIBA
12/2013 - 11/2002
14IntegrinsIBA
01/2021 - 07/2010
10Messenger RNA (mRNA)IBA
02/2014 - 07/2003
8Conditioned Culture MediaIBA
04/2013 - 03/2004
8DNA (Deoxyribonucleic Acid)IBA
02/2013 - 07/2003
8Complementary DNA (cDNA)IBA
07/2011 - 11/2002
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013 - 03/2007
6Transcription Factors (Transcription Factor)IBA
05/2014 - 06/2003
6Matrix Metalloproteinase 2 (Gelatinase A)IBA
09/2010 - 09/2006
6tissue-factor-pathway inhibitor 2 (PP5)IBA
06/2007 - 01/2002
5Cysteine Proteases (Cysteine Protease)IBA
09/2012 - 03/2004
5Thromboplastin (Tissue Factor)IBA
06/2007 - 01/2002
4Double-Stranded RNA (RNA, Double Stranded)IBA
11/2020 - 06/2004
4Cadherins (E-Cadherin)IBA
11/2012 - 03/2011
4Caspase 9IBA
11/2012 - 03/2004
4Therapeutic UsesIBA
06/2012 - 03/2004
4Cytochromes c (Cytochrome c)IBA
02/2012 - 01/2003
4Biological ProductsIBA
01/2012 - 10/2005
4Caspase 8 (Caspase-8)IBA
05/2011 - 10/2009
4CaspasesIBA
10/2008 - 01/2003
3Cysteine (L-Cysteine)FDA Link
02/2013 - 12/2006
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2013 - 09/2010
3Serine Proteases (Serine Protease)IBA
09/2012 - 06/2006
3CateninsIBA
06/2012 - 10/2011
3Metalloproteases (Metalloproteinases)IBA
10/2011 - 06/2004
3EndopeptidasesIBA
04/2011 - 08/2002
3RNA (Ribonucleic Acid)IBA
04/2011 - 05/2004
3Phosphotransferases (Kinase)IBA
03/2011 - 11/2007
3LipidsIBA
12/2010 - 09/2010
3Caspase 3 (Caspase-3)IBA
07/2010 - 05/2009
3NF-kappa B (NF-kB)IBA
06/2008 - 04/2007
3GelatinIBA
03/2008 - 09/2005
3EnzymesIBA
07/2007 - 11/2002
3Protease Inhibitors (Protease Inhibitor)IBA
06/2007 - 12/2002
2CalcineurinIBA
04/2021 - 03/2012
2Histone Deacetylases (Histone Deacetylase)IBA
01/2020 - 12/2007
2VitronectinIBA
10/2013 - 07/2007
2CollagenIBA
10/2013 - 05/2009
2GemcitabineFDA Link
09/2013 - 02/2012
2Angiogenesis InhibitorsIBA
01/2013 - 10/2008
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
11/2012 - 07/2012
2Temozolomide (Temodar)FDA LinkGeneric
11/2012 - 01/2008
2Cyclin D1IBA
07/2012 - 03/2011
2CytokinesIBA
06/2012 - 12/2010
2VimentinIBA
12/2011 - 03/2011
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2011 - 08/2011
2angiogeninIBA
08/2011 - 08/2010
2Pharmaceutical PreparationsIBA
04/2011 - 04/2005
2ZincIBA
04/2011 - 03/2008
2Focal Adhesion Protein-Tyrosine KinasesIBA
02/2011 - 11/2010
2ErbB Receptors (EGF Receptor)IBA
12/2010 - 07/2007
2Integrin alphaVbeta3IBA
09/2010 - 03/2007
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
09/2010 - 01/2003
2Histone Deacetylase InhibitorsIBA
08/2010 - 12/2007
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2010 - 12/2009
2LuciferasesIBA
05/2010 - 01/2002
2MethyltransferasesIBA
01/2010 - 07/2003
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2009 - 01/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2009 - 11/2007
2Mitogen-Activated Protein KinasesIBA
05/2007 - 04/2005
2DecitabineFDA Link
04/2005 - 07/2003
2Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
06/2003 - 01/2002

Therapy/Procedure

39Therapeutics
02/2014 - 12/2002
14Radiotherapy
02/2013 - 06/2008
6Drug Therapy (Chemotherapy)
11/2012 - 06/2007
6Injections
06/2006 - 11/2002
2Aftercare (After-Treatment)
12/2013 - 11/2007
2Intraperitoneal Injections
08/2010 - 07/2007